NO20000752L - Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser - Google Patents
Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelserInfo
- Publication number
- NO20000752L NO20000752L NO20000752A NO20000752A NO20000752L NO 20000752 L NO20000752 L NO 20000752L NO 20000752 A NO20000752 A NO 20000752A NO 20000752 A NO20000752 A NO 20000752A NO 20000752 L NO20000752 L NO 20000752L
- Authority
- NO
- Norway
- Prior art keywords
- disorders
- preventing
- dependent diseases
- treating estrogen
- estrogen
- Prior art date
Links
- 230000001419 dependent effect Effects 0.000 title abstract 3
- 229940011871 estrogen Drugs 0.000 title abstract 3
- 239000000262 estrogen Substances 0.000 title abstract 3
- 208000037765 diseases and disorders Diseases 0.000 title abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 229940046836 anti-estrogen Drugs 0.000 abstract 1
- 230000001833 anti-estrogenic effect Effects 0.000 abstract 1
- 239000000328 estrogen antagonist Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5588197P | 1997-08-15 | 1997-08-15 | |
PCT/US1998/016864 WO1999008682A1 (fr) | 1997-08-15 | 1998-08-14 | Procede de prevention et traitement de maladies et troubles induits par oestrogenes |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20000752D0 NO20000752D0 (no) | 2000-02-15 |
NO20000752L true NO20000752L (no) | 2000-02-15 |
Family
ID=22000784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20000752A NO20000752L (no) | 1997-08-15 | 2000-02-15 | Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser |
Country Status (21)
Country | Link |
---|---|
US (1) | US7307102B2 (fr) |
EP (1) | EP1019057B1 (fr) |
JP (1) | JP2001515038A (fr) |
KR (1) | KR20010022956A (fr) |
CN (1) | CN1275911A (fr) |
AT (1) | ATE411016T1 (fr) |
AU (1) | AU757206B2 (fr) |
BR (1) | BR9811946A (fr) |
CA (1) | CA2301032C (fr) |
CZ (1) | CZ300929B6 (fr) |
DE (1) | DE69840126D1 (fr) |
EE (1) | EE200000077A (fr) |
ES (1) | ES2312189T3 (fr) |
HU (1) | HUP0002852A3 (fr) |
IL (1) | IL134445A0 (fr) |
NO (1) | NO20000752L (fr) |
NZ (1) | NZ502738A (fr) |
PL (1) | PL338555A1 (fr) |
RU (1) | RU2214236C2 (fr) |
UA (1) | UA70925C2 (fr) |
WO (1) | WO1999008682A1 (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6413533B1 (en) * | 1998-05-07 | 2002-07-02 | The University Of Tennessee Research Corporation | Method for chemoprevention of prostate cancer |
JP2003520758A (ja) | 1998-06-12 | 2003-07-08 | リガンド・ファーマシューティカルズ・インコーポレイテッド | 抗エストロゲン耐性乳癌のrxrモジュレーターを用いた処置 |
GB9824207D0 (en) * | 1998-11-04 | 1998-12-30 | Zeneca Ltd | Neurological disorders |
NZ516453A (en) * | 1999-07-06 | 2004-04-30 | Endorech Inc | Methods of treating and/or suppressing weight gain using a selective estrogen receptor modulator |
CO5271709A1 (es) | 2000-01-12 | 2003-04-30 | Pfizer Prod Inc | Composiciones y procedimientos para el y tratamiento de afecciones que responden a estrogenos |
US6417394B2 (en) * | 2000-04-05 | 2002-07-09 | Bristol Myers Squibb Pharma Company | Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulators |
US6528681B2 (en) | 2000-04-05 | 2003-03-04 | Bristol-Meyers Squibb Pharma Company | Halogenated triphenylethylene derivatives as selective estrogen receptor modulators |
AU2001272249A1 (en) * | 2000-07-05 | 2002-01-14 | Andrew J. E. Seely | Method and apparatus for multiple patient parameter variability analysis and display |
WO2002064142A1 (fr) * | 2001-02-15 | 2002-08-22 | Janssen Pharmaceutica N.V. | Combinaisons d'inhibiteurs de la farnesyle proteine transferase avec agents anti-oestrogene |
US20020164581A1 (en) * | 2001-03-12 | 2002-11-07 | Chawnshang Chang | Methods for identifying compounds that do not attenuate the protective effects of estrogen |
SK602004A3 (en) | 2001-08-11 | 2004-11-03 | Bristol Myers Squibb Pharma Co | Selective estrogen receptor modulators |
ATE404188T1 (de) | 2004-06-23 | 2008-08-15 | Sirion Therapeutics Inc | Verfahren und zusammensetzungen zur behandlung von augenerkrankungen mit retinyl-derivaten |
EP1807103A4 (fr) | 2004-11-04 | 2009-02-11 | Sirion Therapeutics Inc | Modulateurs de la formation d'un complexe transthyretine (ttr)-proteine de liaison retinol-retinol (rbp) |
EA010827B1 (ru) * | 2004-12-08 | 2008-12-30 | Сирион Терапьютикс, Инк. | Композиции для лечения ретинол-ассоциированных заболеваний |
US20060264413A1 (en) * | 2005-04-18 | 2006-11-23 | Sri International | Method and composition for inhibiting cell proliferation and angiogenesis |
UA81382C2 (en) * | 2005-07-11 | 2007-12-25 | Composition for treating retinol-related diseases by modulation of retinol binding | |
CN101939738A (zh) * | 2007-10-03 | 2011-01-05 | 渥太华医院研究所 | 用于监控一个或多个器官的随着时间过去的生理参数变异性的方法和装置 |
WO2009151683A2 (fr) | 2008-03-12 | 2009-12-17 | Link Medicine Corporation | Inhibiteurs de quinolinone farnésyl transférase pour le traitement de synucléinopathies et d'autres indications |
EP2370436A1 (fr) | 2008-11-13 | 2011-10-05 | Link Medicine Corporation | Dérivés d'azaquinolinone et leurs applications |
MX2012014431A (es) | 2010-06-10 | 2013-02-26 | Aragon Pharmaceuticals Inc | Modulares del receptor de estrogenos y usos de los mismos. |
US8853423B2 (en) | 2010-06-17 | 2014-10-07 | Seragon Pharmaceuticals, Inc. | Indane estrogen receptor modulators and uses thereof |
GB2483736B (en) | 2010-09-16 | 2012-08-29 | Aragon Pharmaceuticals Inc | Estrogen receptor modulators and uses thereof |
BR112014014124A2 (pt) | 2011-12-14 | 2017-08-22 | Seragon Pharmaceutical Inc | Moduladores do receptor de estrogênio fluorados e usos dos mesmos |
CN102584687A (zh) * | 2011-12-30 | 2012-07-18 | 北京赛林泰医药技术有限公司 | 作为选择性雌激素受体调节剂的乙烯衍生物 |
CN102532073A (zh) * | 2011-12-30 | 2012-07-04 | 北京赛林泰医药技术有限公司 | 作为选择性雌激素受体调节剂的乙烯衍生物 |
CN104220426B (zh) | 2012-03-20 | 2017-03-01 | 塞拉根制药公司 | 雌激素受体调节剂及其用途 |
CA3008020C (fr) * | 2015-12-09 | 2024-02-20 | The Board Of Trustees Of The University Of Illinois | Represseurs du recepteur oestrogenique selectifs a base de benzothiophene |
CN111094227A (zh) * | 2017-07-28 | 2020-05-01 | 里科瑞尔姆Ip控股有限责任公司 | 丙烯酸类似物 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE637389A (fr) | 1962-09-13 | |||
GB1029221A (en) | 1963-09-02 | 1966-05-11 | Ici Ltd | Triarylalkane derivatives |
GB1079747A (en) | 1965-07-07 | 1967-08-16 | Ici Ltd | Alkene derivatives |
US3637856A (en) | 1965-07-12 | 1972-01-25 | Ici Ltd | Trans-1-p-(dialkylaminoalkyl) phenyl-1 2-diphenyl-alk-1-enes and salts thereof |
GB1128379A (en) | 1966-06-20 | 1968-09-25 | Ici Ltd | Novel alkene derivatives, process for the preparation thereof and compositions containing the same |
GB1560274A (en) | 1977-02-28 | 1980-02-06 | Ici Ltd | Phenylbut 1-ene derivatives having antiostrogenicactivity |
EP0002097B1 (fr) | 1977-08-22 | 1981-08-05 | Imperial Chemical Industries Plc | Dérivés de triphénylalcène, procédé pour leur préparation et compositions pharmaceutiques les contenant |
US4206234A (en) | 1977-08-22 | 1980-06-03 | Imperial Chemical Industries Limited | Triphenylbut-1-ene derivatives and pharmaceutical compositions and uses thereof |
EP0019377B1 (fr) | 1979-05-15 | 1982-08-04 | Imperial Chemical Industries Plc | Dérivés de 1-Hydrocarbyloxyphényl-1.2-diphényl alcène, leur préparation et composition pharmaceutique les contenant |
HU178253B (en) | 1979-08-15 | 1982-04-28 | Gyogyszerkutato Intezet | Process for preparing 1,1,2-triphenyl-propane and -propane derivatives |
DE3046719C2 (de) | 1980-12-11 | 1983-02-17 | Klinge Pharma GmbH, 8000 München | 1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel |
FI77839C (fi) | 1982-05-27 | 1989-05-10 | Farmos Oy | Foerfarande foer framstaellning av nya terapeutiskt effektiva trifenylalkan- och alkenderivat. |
US5491173A (en) * | 1982-06-25 | 1996-02-13 | Orion-Yhtyma Oy | Tri-phenyl alkene derivatives and their preparation and use |
CA1229604A (fr) | 1984-02-14 | 1987-11-24 | Lorne J. Brandes | Ethers aminoalkyl de phenols utilises comme agents antiproliferatifs contre le cancer |
US4760053A (en) | 1984-08-02 | 1988-07-26 | Fernand Labrie | Combination therapy for selected sex steroid dependent cancers |
US4729999A (en) | 1984-10-12 | 1988-03-08 | Bcm Technologies | Antiestrogen therapy for symptoms of estrogen deficiency |
GB8604528D0 (en) | 1986-02-24 | 1986-04-03 | Ici Plc | Therapeutic agents |
US4859695A (en) | 1986-06-10 | 1989-08-22 | Merck & Co., Inc. | Antiestrogen agents having anabolic activity in animals |
CA1289570C (fr) | 1986-06-16 | 1991-09-24 | Tetsuji Asao | Derives 1,1,2-triaryl-1-alcenes |
DE3736682A1 (de) | 1987-10-29 | 1989-05-11 | Klinge Co Chem Pharm Fab | Verfahren zur herstellung von trans-1,1,2-triphenyl-but-1-en-derivaten |
US5393785A (en) | 1988-10-31 | 1995-02-28 | Endorecherche, Inc. | Therapeutic antiestrogens |
US5119827A (en) | 1990-09-05 | 1992-06-09 | Board Of Regents, The University Of Texas System | Mechanisms of antiestrogen resistance in breast cancer |
US5189212A (en) * | 1990-09-07 | 1993-02-23 | University Of Georgia Research Foundation, Inc. | Triarylethylene carboxylic acids with estrogenic activity |
CA2092996A1 (fr) | 1990-10-01 | 1992-04-02 | David Yang | Derives de tamoxifene a haute affinite et utilisation |
AU659157B2 (en) | 1991-04-30 | 1995-05-11 | Asahi Kasei Kogyo Kabushiki Kaisha | Triphenylethylene derivative and pharmaceutical preparation containing the same |
DE69316633T2 (de) | 1992-09-15 | 1998-05-20 | Merrell Dow Pharma | Nichtmetabolisierbare clomiphene-analoge zur behandlung von tamoxifen-resistenten tumoren |
DE4311870C2 (de) * | 1993-04-10 | 1998-07-30 | Altramed Holdings Ltd | Verwendung eines Anti-Östrigens zur Therapie und Prophylaxe von Demenz-Erkrankungen |
US5681835A (en) | 1994-04-25 | 1997-10-28 | Glaxo Wellcome Inc. | Non-steroidal ligands for the estrogen receptor |
US5455275A (en) * | 1994-05-11 | 1995-10-03 | Eli Lilly And Company | Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives |
-
1998
- 1998-08-14 RU RU2000106448/14A patent/RU2214236C2/ru not_active IP Right Cessation
- 1998-08-14 NZ NZ502738A patent/NZ502738A/en unknown
- 1998-08-14 EP EP98940886A patent/EP1019057B1/fr not_active Expired - Lifetime
- 1998-08-14 UA UA2000020847A patent/UA70925C2/uk unknown
- 1998-08-14 CA CA002301032A patent/CA2301032C/fr not_active Expired - Fee Related
- 1998-08-14 CN CN98810214A patent/CN1275911A/zh active Pending
- 1998-08-14 EE EEP200000077A patent/EE200000077A/xx unknown
- 1998-08-14 AU AU89063/98A patent/AU757206B2/en not_active Ceased
- 1998-08-14 AT AT98940886T patent/ATE411016T1/de not_active IP Right Cessation
- 1998-08-14 BR BR9811946-0A patent/BR9811946A/pt not_active IP Right Cessation
- 1998-08-14 WO PCT/US1998/016864 patent/WO1999008682A1/fr not_active Application Discontinuation
- 1998-08-14 HU HU0002852A patent/HUP0002852A3/hu unknown
- 1998-08-14 ES ES98940886T patent/ES2312189T3/es not_active Expired - Lifetime
- 1998-08-14 CZ CZ20000531A patent/CZ300929B6/cs not_active IP Right Cessation
- 1998-08-14 KR KR1020007001564A patent/KR20010022956A/ko active Search and Examination
- 1998-08-14 PL PL98338555A patent/PL338555A1/xx unknown
- 1998-08-14 JP JP2000509421A patent/JP2001515038A/ja active Pending
- 1998-08-14 IL IL13444598A patent/IL134445A0/xx not_active IP Right Cessation
- 1998-08-14 DE DE69840126T patent/DE69840126D1/de not_active Expired - Fee Related
-
2000
- 2000-02-15 NO NO20000752A patent/NO20000752L/no not_active Application Discontinuation
-
2003
- 2003-03-18 US US10/390,032 patent/US7307102B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1019057A1 (fr) | 2000-07-19 |
NO20000752D0 (no) | 2000-02-15 |
DE69840126D1 (de) | 2008-11-27 |
AU8906398A (en) | 1999-03-08 |
EP1019057B1 (fr) | 2008-10-15 |
ES2312189T3 (es) | 2009-02-16 |
EE200000077A (et) | 2000-12-15 |
AU757206B2 (en) | 2003-02-06 |
EP1019057A4 (fr) | 2006-06-14 |
HUP0002852A3 (en) | 2001-11-28 |
KR20010022956A (ko) | 2001-03-26 |
CZ300929B6 (cs) | 2009-09-16 |
BR9811946A (pt) | 2000-08-22 |
HUP0002852A2 (hu) | 2001-10-28 |
ATE411016T1 (de) | 2008-10-15 |
CA2301032A1 (fr) | 1999-02-25 |
UA70925C2 (uk) | 2004-11-15 |
CZ2000531A3 (en) | 2001-05-16 |
CN1275911A (zh) | 2000-12-06 |
JP2001515038A (ja) | 2001-09-18 |
NZ502738A (en) | 2002-06-28 |
WO1999008682A1 (fr) | 1999-02-25 |
RU2214236C2 (ru) | 2003-10-20 |
US20030232795A1 (en) | 2003-12-18 |
US7307102B2 (en) | 2007-12-11 |
PL338555A1 (en) | 2000-11-06 |
IL134445A0 (en) | 2001-04-30 |
CA2301032C (fr) | 2009-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20000752L (no) | Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser | |
ATE208382T1 (de) | Konjugate von cis-docosahexaensäure und paclitaxel | |
FI965269A0 (fi) | Menetelmä syövän etäispesäkkeen ehkäisemiseksi modifioidun citrus pektiinin avulla | |
ATE425749T1 (de) | Behandlung von mit her-2/neu-uberexprimierung einhergehendem krebs | |
DE69826695D1 (de) | Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen | |
CY1109525T1 (el) | ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΑ ΑΝΤΙΣΩΜΑΤΑ ΑΝΤΙ-ErbB2 ΚΑΙ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΜΕ ΑΝΤΙΣΩΜΑΤΑ ΑΝΤΙ-ErbB2 | |
GB9815177D0 (en) | Treatment of skin disorders | |
ATE258796T1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
ATE239509T1 (de) | Konjugate zur behandlung von prostatakrebs | |
PT1109571E (pt) | Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos | |
DE69927688D1 (de) | Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs | |
BR9917495A (pt) | Derivados o ácido betulìnico tendo atividade antiangiogênica, processos para produzir tais derivados e sua utilização para o tratamento de antiogênese associada a tumores | |
ATE261724T1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen | |
MD1569G2 (ro) | Metodă de tratament al cancerului mamar în perioada preoperatorie | |
DE69835828D1 (de) | Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression | |
MXPA01007031A (es) | Metodo para tratar enfermedades acrdiacas cronicas. | |
DE60212415D1 (de) | Die verwendung von einer 4-pyridylmethylphtalazine enthaltenden kombination zur behandlung von tumoren | |
GB9723824D0 (en) | Cytostatic agents | |
IL159469A0 (en) | Xenogenic oligo-or/and polyribonucleotides as agents for the treatment of malignant tumours | |
UA34375A (uk) | Спосіб лікування рака молочної залози | |
ATE249229T1 (de) | Verwendung von putamen ovi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |